# Palmer Square Capital BDC Inc.: overview PSBD · NYSE · CIK 1794776 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/psbd.md) · [Financials](/companies/psbd/financials.md) · [Filings](/companies/psbd/filings.md) · [Insiders](/companies/psbd/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.48](/filings/0001193125-25-265688.md) | not reported | [0.40](/filings/0000950170-25-064975.md) | [0.43](/filings/0000950170-25-103522.md) | [0.43](/filings/0001193125-25-265688.md) | not reported | not reported | not reported | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.47](/filings/0001213900-24-017740.md) | [1.78](/filings/0000950170-25-028337.md) | [2.26](/filings/0001193125-26-073362.md) | [1.93](/filings/0001193125-26-073362.md) | [1.66](/filings/0001193125-26-073362.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/psbd/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [OV Management LLC](/funds/2010766.md) | 2026-06-30 | $38.9m | 3,730,065 | | Unchanged | | [1248 Management, LLC](/funds/2011147.md) | 2026-06-30 | $34.4m | 3,186,701 | | Added +231,988 | | [Mariner, LLC](/funds/1373442.md) | 2026-06-30 | $32.9m | 3,160,003 | | Added +79,898 | | [First Trust Capital Management L.P.](/funds/1604488.md) | 2026-06-30 | $13.4m | 1,288,337 | | Unchanged | | [Pandi, LLC](/funds/2058702.md) | 2026-06-30 | $9.5m | 911,854 | | Unchanged | | [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $7.0m | 669,631 | | Added +92,700 | | [Arlington Partners LLC](/funds/1389848.md) | 2026-06-30 | $5.3m | 510,344 | | Unchanged | | [Bienville Capital Management, LLC](/funds/1605070.md) | 2026-06-30 | $4.6m | 425,379 | | Reduced −99,843 | | [Sunesis Advisors, LLC](/funds/1748269.md) | 2026-06-30 | $3.1m | 298,959 | | Unchanged | | [Hennion & Walsh Asset Management, Inc.](/funds/1861642.md) | 2026-06-30 | $2.1m | 198,062 | | Reduced −15,878 | ## Recent filings [All 233 filings](/companies/psbd/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-13 | 20:15 ET | [8-K](/filings/0001193125-26-420436.md) | 8.01 Other events | 0001193125-26-420436 | | 2026-09-22 | 20:15 ET | [8-K](/filings/0001193125-26-397933.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-397933 | | 2026-09-15 | 20:15 ET | [8-K](/filings/0001193125-26-391940.md) | 8.01 Other events | 0001193125-26-391940 | | 2026-08-17 | 21:16 ET | [8-K](/filings/0001193125-26-354292.md) | 8.01 Other events | 0001193125-26-354292 | | 2026-08-07 | 20:19 ET | [8-K](/filings/0001213900-26-086702.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-086702 | | 2026-08-05 | 20:15 ET | [8-K](/filings/0001193125-26-335145.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-335145 | | 2026-08-05 | 10:56 ET | [10-Q](/filings/0001193125-26-333791.md) | Quarterly report, period 2026-06-30 | 0001193125-26-333791 | | 2026-07-15 | 20:52 ET | [8-K](/filings/0001213900-26-078363.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-078363 | | 2026-07-14 | 20:15 ET | [8-K](/filings/0001193125-26-303189.md) | 8.01 Other events | 0001193125-26-303189 | | 2026-06-25 | 20:15 ET | [8-K](/filings/0001213900-26-072055.md) | 1.01 Entry into a material agreement | 0001213900-26-072055 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-073362.md), filed Feb 26, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1794776 - Tickers: PSBD - Exchange: NYSE - SIC code: not reported - State of incorporation: MD - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.